Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Review Article Volume 6 Issue 9

The Omphalic Canker-Intrahepatic Cholangiocarcinoma

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: June 06, 2023; Published: August 10, 2023

Abstract

Intrahepatic cholangiocarcinoma emerges as a malignant, intrahepatic, epithelial neoplasm delineating biliary differentiation. As categorized by World Health Organization (WHO) in 2019, neoplasm may incriminate peripheral hepatic parenchyma or arise proximal to left hepatic duct and right hepatic duct. Additionally designated as peripheral cholangiocarcinoma or intrahepatic bile duct carcinoma, the non encapsulated, firm, white or tan intrahepatic glandular malignancy demonstrates variable cellular differentiation with cellular or nuclear atypia. Neoplasm appears to infiltrate circumscribing dense, fibrous stroma.

 Keywords: World Health Organization (WHO); Peripheral Hepatic Parenchyma

References

  1. Lotfollahzadeh S., et al. “Hepatobiliary Tract Cancer”. Stat Pearls International: Treasure Island, Florida (2022).
  2. Lin CR., et al. “Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study”. World Journal of Gastroenterology28 (2022): 3695-3705.
  3. O'Hagan K. “Updates in Cholangiocarcinoma”. Journal of the Advanced Practitioner in Oncology3 (2022): 320-323.
  4. Song Y., et al. “The focus clinical research in intrahepatic cholangiocarcinoma”. European Journal of Medical Research1 (2022): 116.
  5. Zhang X., et al. “Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update”. Intractable and Rare Diseases Research4 (2022): 161-172.
  6. Image 1 Courtesy: Wikipedia.
  7. Image 2 Courtesy: Libre Pathology.

Citation

Citation: Anubha Bajaj. “The Omphalic Canker-Intrahepatic Cholangiocarcinoma". Acta Scientific Gastrointestinal Disorders 6.9 (2023): 20-24.

Copyright

Copyright: © 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US